Mankind Pharma Limited has informed the Exchange regarding a press release dated August 20, 2026, titled "Mankind Pharma Enters into Exclusive In-Licensing Agreement for Insulin Degludec and Insulin Degludec + Aspart Combination for India".
Mankind Pharma Ltd. Press Release Aug 20 2026
Filed with NSE · · 3 pages · English
Release
Earlier from Mankind Pharma
- Mankind Pharma Ltd. Press Release Jul 30 2026
- Press Release May 19 2026
- Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Press Release Mar 18 2026
- Press Release Feb 03 2026
Later from Mankind Pharma
- Mankind Pharma Limited has informed the Exchange regarding a press release dated October 15, 2026, titled "Press Release titled Mankind Pharma to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-Generation CAR-T Therapies ".
- Mankind Pharma Limited has informed the Exchange regarding a press release dated October 26, 2026, titled "Press Release on Financial Results for Q2 & H1 FY27".
Follow Mankind Pharma into a list and get an email when it puts out news.
Follow Mankind Pharma